Amber Wezenaar is a researcher and entrepreneur specializing in immunotherapy. Her work focuses on applying advanced imaging technologies to study immunotherapies for solid tumors, driving the development of more effective treatments. 

She is currently in the early stages of fouding a start-up dedicated to engineered T cell therapies and recently won the Venture Challenge with her venture.